Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Korea-Seoul Life Science Fund is a specialized venture capital fund established to catalyze the growth of the biotechnology and healthcare sectors in Seoul, South Korea. Launched as part of the Seoul Metropolitan Government's Seoul Vision 2030 initiative, the fund provides critical investment to early-stage startups and growth-stage companies specializing in drug discovery, medical devices, and digital health. It is managed by professional venture capital firms, such as Hanwha Investment & Securities and Daily Partners, which select portfolio companies based on their potential for global innovation. By bridging the funding gap for high-risk research, the fund aims to solidify Seoul's position as a premier global hub for life science innovation. The fund also works in tandem with the Seoul Bio Hub to provide infrastructure and networking support to its investees.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korea-Seoul Life Science Fund.